Trade Summary

6 days ago, Ye Weiguo, serving as Chief Operating Officer at GYRE THERAPEUTICS, INC. (GYRE), sold 22,220 shares at $6.15 per share, for a total transaction value of $136,653.00. Following this transaction, Ye Weiguo now holds 700,000 shares of GYRE.

This sale represents a 3.08% decrease in Ye Weiguo's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, May 21, 2026 and publicly disclosed via SEC Form 4 filing on Friday, May 22, 2026 at 6:19 PM ET, 1 day after the trade was made.